Dr. William E. Beckerman, MD

Dr. Beckerman practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Beckerman's NPI, 1275976946, was assigned on April 12, 2013. Dr. Beckerman holds New Jersey license 25MA10325800.

Dr. Beckerman's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Beckerman also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Beckerman's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. Dr. Beckerman is also affiliated with Princeton Medical Center. The medical group on file is Rutgers Robert Wood Johnson Medical Group. Dmand AI also links Dr. Beckerman to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beckerman practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Beckerman's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Beckerman is licensed in New Jersey.

CMS data shows 689 Medicare services from Dr. Beckerman across 14 procedure codes in 2024, for 434 Medicare patients. Medicare paid $45,115 for them.

CMS counts 434 Medicare patients who saw Dr. Beckerman in 2024. The largest group is 75 to 84, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beckerman's median patient age at 74, with 39% women.

In 2024, Dr. Beckerman wrote 254 Medicare Part D claims for 61 patients. 79% of them were for generic drugs. CMS names the drug for 187 of them, across 5 drugs with 11 or more claims each, at $35,637 in total drug cost. In 2023, CMS named 116 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Beckerman for performance year 2024, reported as part of a group. Dr. Beckerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beckerman as offering telehealth. CMS counts 40 procedures of leg revascularization (restoring blood flow) by Dr. Beckerman, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 31 papers to Dr. Beckerman, published from 2015 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Endovascular Procedures, Aortic Aneurysm, Abdominal and Blood Vessel Prosthesis Implantation. Dr. Beckerman has published most often in Ann Vasc Surg. Dr. Beckerman's most frequent co-authors are Saum Amir Rahimi, MD, Peter L. Faries, MD and Rami Odeh Tadros, MD.

CMS Open Payments shows 568 general payments to Dr. Beckerman from 34 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 36% of the total. ShockWave Medical, Inc paid the most, $66,035.